Tibolone
- TRADE NAME: Livial (Organon)
- INDICATIONS: Estrogen deficiency, prevention of osteoporosis
- CLASS: Androgen agonist, Derivative of norethynodel, Estrogen agonist, Progesterone agonist, Selective estrogen receptor modulator (SERM)
- HALF-LIFE: 1–4 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
CYP3Q4 inducers, Midazolam, St John's Wort, Warfarin
Please login to see the rest of this drug profile
SKIN.
HAIR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
HEMATOLOGIC.
NEUROMUSCULAR/SKELETAL.
OCULAR.
OTHER.
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric